针对耐药结核病的以患者为中心的干预措施:范围审查
Ndiviwe Mphothulo1, Marian Loveday, Hanlie Myburg
1Department of Nursing and Public Health, Faculty of Health Sciences, University of KwaZulu-Natal, Durban. 221101668@ukzn.ac.za.
概括
以患者为中心的护理干预措施,包括信息,情感,陪伴和物质支持,显著改善了耐药结核病 (DR-TB) 患者的保留和结果. 这些策略有助于克服治疗挑战.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 患者护理 患者护理
背景情况:
- 耐药结核病 (DR-TB) 治疗存在重大挑战,包括严重的疾病,副作用和心理社会/社会经济困难.
- 这些挑战会对患者的坚持和治疗完成率产生负面影响.
研究的目的:
- 综合关于以患者为中心的护理干预措施的证据,旨在改善DR-TB患者在护理中的保留.
- 识别和分类为接受DR-TB治疗的个人提供的不同类型的支持.
主要方法:
- 进行了全面的范围审查,检查了2005年至2023年间发表的研究.
- 文献来源于初级研究文章,灰色文献和同行评审的评论文章.
- 在最初获取的347项研究中,对14项被选中的研究应用了纳入标准.
主要成果:
- 针对DR-TB患者的以患者为中心的干预措施被分为信息,情感,陪伴和物质支持,符合世卫组织的建议.
- 物质支持是最常用的干预措施 (12项研究),其次是信息 (9项研究),伴侣 (7项研究) 和情感支持 (5项研究).
- 大多数研究 (11) 整合了多种形式的DR-TB患者的支持.
结论:
- 以患者为中心的护理干预措施有效地提高了DR-TB患者在护理中的保留率,并改善了DR-TB患者的治疗结果.
- 这项研究强调了定制,以患者为中心的支持在有效管理DR-TB方面发挥的关键作用.
相关概念视频
Pulmonary Tuberculosis V
523
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
523
Pulmonary Tuberculosis IV
468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
Pulmonary Tuberculosis I
802
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
802
Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K


